Independent product profile
Arden Grange Senior Chicken & Rice
Read the recorded recipe, market, intended use and review status below.
Product and intended use
Recorded editorial overview
This earlier overview is retained for context. Check the declarations and review status below before relying on its classification or suitability statements.
A UK complete dry dog food from Arden Grange, intended for senior dogs. This record covers the senior chicken & rice product.
Manufacturer declarations describe the label. EP interpretation and ingredient research do not establish the efficacy or suitability of this finished product.
Recorded declarations and sources
Arden Grange Senior Chicken & Rice, partial composition summary
Fat Content: 12%
Crude Ash: 6%
Crude Fibres: 3.5%
Calcium: 1%
Phosphorus: 0.75%
The checked date records when EP inspected or captured the source. It does not establish when the recipe changed. Calculations require verified values with a compatible basis and qualifiers.
Additional recorded source captures
- Recorded formulation source. EP checked: 2026-09-24. Capture scope: Declaration on the named formulation.
A source capture records the information available within that scope. It does not by itself complete label verification or establish product efficacy.
Ingredients in context
Read the original composition and declaration coverage for each recipe above. Reviewed ingredient links appear below. Partial summaries do not establish every ingredient or its quantity.
Manufacturer claims and evidence
These statements are attributed to the manufacturer. They are separate from EP interpretation and independently reviewed ingredient research.
Arden Grange positions this recipe for the life stage and feeding purpose stated above, with digestive and nutritional support claims. This entry records its label information without treating marketing descriptions as verified clinical outcomes.
Ingredient research does not establish an effect of this finished product.
What deserves a closer look?
Glucosamine 740 mg/kg, MSM 740 mg/kg and chondroitin 520 mg/kg are listed. Their inclusion does not establish a clinical mobility benefit from this finished recipe.
Useful questions for the manufacturer include who formulated the recipe, how nutritional adequacy is checked, whether full nutrient and energy data are available, and whether any cited research used this exact formulation.
Connected ingredients and evidence
Browse dog evidence · Compare other dog product profiles
These links provide context, not an efficacy grade. Check the study species, preparation, amount and outcome before transferring a result to this food.
Reviewed ingredient research context
These are reviewed ingredient connections for Arden Grange Senior Chicken & Rice, partial composition summary. Direct describes an ingredient relationship, not proof for this commercial product. No ingredient study is treated as a test of this finished product.
FOS and MOS in dogs: digestion, microbes and immune markers
One study, 2 reviewed ingredient or arm connection(s).
Fructo-oligosaccharides (FOS); arm fos-supplement
Declared occurrence: prebiotic FOS. Tested preparation: FOS supplied at 1 g per feeding, twice daily.. Population: Four adult female dogs with ileal cannulas; 14-day periods..
Study dose: 1 g per feeding, twice daily. Oral feeding supplement.. Duration: 14-day periods.. Comparator: The same kibble without these supplements..
Measured outcome: Digestibility, microbial populations, protein-breakdown products, and immune indices.. Finding within this study: FOS-containing treatments lowered faecal indoles and phenols. Combined FOS/MOS increased ileal IgA versus control; several reported effects were only trends.
Applicability and limitations: Very small, surgically instrumented population; short periods and multiple surrogate outcomes. Related papers may share experiments. Only for published UK dog products whose active formulation has a verified FOS ingredient line. This study tested a separate FOS supplement in four cannulated adult female dogs; it is ingredient context, not a finished-product or life-stage test. Preparation equivalence is not established by this declaration. Product inclusion quantity is not declared. A declared ingredient amount does not establish intake of the study dose. The formulation declaration is disputed or awaits label verification.
Abstract reviewed; source reviewed 2026-09-25.
Mannan-oligosaccharides (MOS); arm mos-supplement
Declared occurrence: prebiotic MOS. Tested preparation: MOS supplied at 1 g per feeding, twice daily.. Population: Four adult female dogs with ileal cannulas; 14-day periods..
Study dose: 1 g per feeding, twice daily. Oral feeding supplement.. Duration: 14-day periods.. Comparator: The same kibble without these supplements..
Measured outcome: Digestibility, microbial populations, protein-breakdown products, and immune indices.. Finding within this study: MOS changed some immune and microbial measures; several reported effects were only trends. Combined FOS/MOS increased ileal IgA versus control.
Applicability and limitations: Very small, surgically instrumented population; short periods and multiple surrogate outcomes. Related papers may share experiments. Only for published UK dog products whose active formulation has a verified MOS ingredient line. This study tested a separate MOS supplement in four cannulated adult female dogs; it is ingredient context, not a finished-product or life-stage test. Preparation equivalence is not established by this declaration. Product inclusion quantity is not declared. A declared ingredient amount does not establish intake of the study dose. The formulation declaration is disputed or awaits label verification.
Abstract reviewed; source reviewed 2026-09-25.
Protein level changes the response to FOS in dogs
One study, 1 reviewed ingredient or arm connection(s).
Fructo-oligosaccharides (FOS); arm fos-in-protein-factorial
Declared occurrence: prebiotic FOS. Tested preparation: Fructo-oligosaccharide (FOS) added to lower- and higher-protein foods; inclusion level not reported in the reviewed abstract.. Population: 12 healthy adult dogs in a replicated four-treatment Latin square..
Study dose: Not reported in the reviewed abstract. Food inclusion; amount not reported.. Duration: 28-day periods with washouts.. Comparator: Corresponding unsupplemented foods..
Measured outcome: Faecal fermentation, microbes, and apparent digestibility.. Finding within this study: Higher protein and FOS each increased faecal ammonia. FOS increased apparent digestibility of several minerals; protein level modified some FOS effects, including bifidobacteria and protein digestibility.
Applicability and limitations: Faecal measurements are surrogate outcomes. Small healthy population; no disease-treatment endpoint. Only for published UK dog products whose active formulation has a verified FOS ingredient line. The study tested FOS in different protein diets in healthy adult dogs; it is ingredient context, not a finished-product or life-stage test. Preparation equivalence is not established by this declaration. Product inclusion quantity is not declared. A declared ingredient amount does not establish intake of the study dose. The formulation declaration is disputed or awaits label verification.
Abstract reviewed; source reviewed 2026-09-25.
Source and review scope
Current sources, checked dates, unresolved conflicts and declaration coverage appear with each recorded formulation above. Source capture, label verification, ingredient matching and evidence appraisal are separate review steps.
Further source and evidence review remains pending